Hypercholesterolemia impairs transduction of vasodilator signals derived from ischemic myocardium:

Kouichi Sato1, Tatsuya Komaru, Hiroki Shioiri

  • 1Department of Cardiovascular Medicine, Tohoku University, Graduate School of Medicine, Sendai, Japan.

Insights

In hypercholesterolemia, coronary microvessels fail to dilate during myocardial ischemia. This impairment is linked to increased oxidative stress, affecting vasodilator signal transduction.

Area of Science:

  • Cardiovascular Physiology
  • Vascular Biology
  • Metabolic Syndrome

Background:

  • Coronary microvessels are crucial for regulating myocardial blood flow in response to metabolic demand.
  • Hypercholesterolemia is associated with widespread vascular dysfunction, including at the microvascular level.
  • The precise mechanisms impairing microvascular vasodilator signal transduction in hypercholesterolemia remain incompletely understood.

Purpose of the Study:

  • To investigate whether vasodilator signal transduction from ischemic myocardium is impaired in the coronary microvascular wall of hypercholesterolemia.
  • To explore the role of oxidative stress in this potential microvascular dysfunction.

Main Methods:

  • Rabbits were fed either a normal chow or a high-cholesterol diet for 8 weeks to induce hypercholesterolemia.
  • Isolated coronary microvessels were pressurized and superfused on a beating canine heart model.
  • Myocardial ischemia was induced, and microvessel diameter changes were observed using intravital microscopy.
  • Superoxide levels were assessed using dihydroethidium fluorescence, and the effect of tiron (a free radical scavenger) was evaluated.

Main Results:

  • Control group microvessels demonstrated significant dilation upon ischemia onset, reaching a plateau.
  • Microvessels from hypercholesterolemic rabbits failed to dilate during ischemia.
  • Elevated superoxide levels were detected in microvessels of hypercholesterolemic rabbits.
  • Tiron administration significantly improved microvessel dilation in hypercholesterolemic animals.

Conclusions:

  • The transduction of vasodilator signals from ischemic myocardium is impaired in the coronary microvascular wall in hypercholesterolemia.
  • Increased oxidative stress in hypercholesterolemia contributes to the observed microvascular dysfunction.
  • These findings highlight a critical microvascular defect in hypercholesterolemia that may compromise myocardial perfusion during ischemic events.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...